Ten male patients with T2DM were enrolled in this clinical trial and received either of the treatment arms: 300 U oral insulin combined with 400 mg 4-CNAB or 15 U regular SC insulin injection as a control on a separate dosing day. Here, INS is linked to type 2 diabetes mellitus.